Hallie Kuhn
Fortuna: 3 M $ al 30/06/2026
Fortuna: 3 M $ al 30/06/2026
Hallie Kuhn currently works at Molecular Assemblies, Inc., as Director, Eclipse Bioinnovations, Inc., as Director from 2022, Alexandria Real Estate Equities, Inc., as Executive Vice President-Capital Markets from 2026, and Alexandria Venture Investments LLC, as Vice President of Science & Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/04/2026 | 48.301 ( 0,03 % ) | 3 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | Corporate Officer/Principal | 01/01/2026 |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Develops enzymatic DNA synthesis technology used for making DNA-based products | Director/Miembro de la Junta | - |
Eclipse Bioinnovations, Inc.
Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Develops technologies platform for RNA medicines | Director/Miembro de la Junta | 15/03/2022 |
Alexandria Venture Investments LLC
Alexandria Venture Investments LLC Investment ManagersFinance Alexandria Venture invests in companies located in the United States. The firm targets companies operating in disruptive life science, innovative medicine and technology. It provides financing for seed, early and growth stage capital requirements. | Inversor de Capital Privado | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Alexandria Real Estate Equities, Inc.
Alexandria Real Estate Equities, Inc. Real Estate Investment TrustsFinance Operates as a real estate investment trust which leases life science, agri-tech, and advanced technology mega campuses | Finance |
Alexandria Venture Investments LLC
Alexandria Venture Investments LLC Investment ManagersFinance Alexandria Venture invests in companies located in the United States. The firm targets companies operating in disruptive life science, innovative medicine and technology. It provides financing for seed, early and growth stage capital requirements. | Finance |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Develops enzymatic DNA synthesis technology used for making DNA-based products | Health Technology |
Eclipse Bioinnovations, Inc.
Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Develops technologies platform for RNA medicines | Technology Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.